NFKB1 and depressive symptom measurement: Proteins involved in NF-κB signaling, chromatin remodeling, and energy metabolism were normalized, indicating its potential role in mitigating neuroinflammation, epigenetic dysregulation, and metabolic imbalance associated with depression.